Optometrists in Winslow, AZ Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Dr. Christian Jay Thompson, O.D., F.A.A.O. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 500 Indiana Ave, Winslow, AZ 86047 Phone: 928-245-3732 |
Steven Gregory Zeldes, OD Optometrist Medicare: Medicare Enrolled Practice Location: 500 Indiana Ave, Winslow, AZ 86047 Phone: 928-289-6224 Fax: 928-289-6290 |
Kevin Rowe, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 500 Indiana Ave, Winslow, AZ 86047 Phone: 928-289-4646 Fax: 928-289-6290 |
Michael John Schumacher, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 500 Indiana Ave, Winslow, AZ 86047 Phone: 928-640-2598 |
News Archive
Researchers focus on optimal use of immune agents in frontline setting for NSCLC treatment
Immunotherapy continues to revolutionize the field of non-small cell lung cancer (NSCLC), with researchers now focusing on the optimal use of immune agents in the frontline setting.
Latest Atmospheric Control Unit now available for BMG LABTECH's budget-friendly product line
Cell-based assays have become an important application in the life science sector, from basic to top-level research. They are widely used in biotech companies and academic research institutions to monitor cell health in real-time.
Hain Celestial Group announces acquisition of Belvedere International
The Hain Celestial Group, Inc., a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life, today announced the acquisition of Belvedere International, Inc., a leader in health and beauty care products including the Live Clean brand with approximately 200 baby, body and hair care products as well as several mass market brands sold primarily in Canada and manufactured in a company facility in Mississauga, Ontario, Canada.
Why glaring quality gaps among nursing homes are likely to grow if Medicaid is cut
Nursing homes that rely the most on Medicaid tend to provide the worst care for their residents — not just the people covered by the program but also those who pay privately or have Medicare coverage.
Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress
Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.
› Verified 3 days ago
Physical Therapists
Chiropractors
Optometrists
Speech-Language Pathologists